You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • SAT0454 In A Two-Year Double-Blind Randomized Controlled Multicenter Study, Chondroitin Sulfate Was Significantly Superior To Celecoxib at Reducing Cartilage Loss with Similar Efficacy at Reducing Disease Symptoms In Knee Osteoarthritis Patients

Citation Tools

Article menu
Download PDFPDF
Poster Presentations
Osteoarthritis
SAT0454 In A Two-Year Double-Blind Randomized Controlled Multicenter Study, Chondroitin Sulfate Was Significantly Superior To Celecoxib at Reducing Cartilage Loss with Similar Efficacy at Reducing Disease Symptoms In Knee Osteoarthritis Patients

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Pelletier J, Raynauld J, Beaulieu A, et al
SAT0454 In A Two-Year Double-Blind Randomized Controlled Multicenter Study, Chondroitin Sulfate Was Significantly Superior To Celecoxib at Reducing Cartilage Loss with Similar Efficacy at Reducing Disease Symptoms In Knee Osteoarthritis Patients
Annals of the Rheumatic Diseases 2016;75:836.